Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

DiaMonTech AG, DE000A255G44

DiaMonTech AG, DE000A255G44

25.11.2019 - 09:03:06

DiaMonTech AG: DAK-Gesundheit and DiaMonTech plan strategic cooperation in the non-invasive blood glucose monitoring sector for new treatment strategies in the diabetes sector

25.11.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: DiaMonTech AG Boxhagener Straße 82a 10245 Berlin

Germany Phone: +49 30 50175936 Internet: www.diamontech.de ISIN: DE000A255G44 WKN: A255G4 Listed: Regulated Market in Frankfurt (Prime Standard) EQS News ID: 920217 Notierung vorgesehen / designated to be listed   End of News DGAP News Service

920217  25.11.2019 

@ dgap.de